Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-05-14

Clinical Trial Update: Use Cord Blood Single Nucleotide Polymorphism to Predict the Later Development of Atopy and Allergy

View source ↗

Summary

A clinical trial update examines whether cord blood single nucleotide polymorphisms can predict the later development of atopy and allergic diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Min-Sheng General Hospital | Conditions: Atopy, Allergic Disease | Status: UNKNOWN